ARTICLE | Company News
Chugai submits Japanese NDA for alectinib
October 9, 2013 12:31 AM UTC
Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) submitted an NDA to Japan's Ministry of Health, Labor and Welfare (MHLW) for alectinib ( RO5424802/ CH5424802) to treat anaplastic lymphoma kinase (ALK)-pos...